Poor accuracy and sustainability of the first-step FIB4 EASL pathway for stratifying steatotic liver disease risk in the general population.
Antonio De VincentisFederica TavaglioneShinichi NambaMasahiro KanaiYukinori OkadaYoichiro KamataniSamantha MaurottiClaudio PedoneRaffaele Antonelli IncalziLuca Vittorio ValentiStefano RomeoUmberto Vespasiani-GentilucciPublished in: Alimentary pharmacology & therapeutics (2024)
The first-step FIB4 EASL CP is poorly accurate and feasible for individuals at risk of SLD in the general population. It is crucial to enhance the screening strategy with a first-step approach able to reduce unnecessary VCTEs and optimise their yield.
Keyphrases